Putting Proteomics Into Immunotherapy for Glioblastoma
Sign Up to like & getrecommendations! Published in 2021 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2021.593255
Abstract: In glioblastoma, the most aggressive brain cancer, a complex microenvironment of heterogeneity and immunosuppression, are considerable hurdles to classify the subtypes and promote treatment progression. Treatments for glioblastoma are similar to standard therapies for many… read more here.
Keywords: proteomics immunotherapy; putting proteomics; immunotherapy glioblastoma; glioblastoma ... See more keywords